featured
Safety and Clinical Activity of Ivosidenib in Patients With Advanced Chondrosarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
J. Clin. Oncol 2020 Mar 24;[EPub Ahead of Print], WD Tap, VM Villalobos, GM Cote, H Burris, F Janku, O Mir, M Beeram, AJ Wagner, L Jiang, B Wu, S Choe, K Yen, C Gliser, B Fan, S Agresta, SS Pandya, JC TrentFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.